Serum complement factor I decreases Staphylococcus aureus phagocytosis

Journal of Laboratory and Clinical Medicine

Volumn 146, Issue 5, 2005, Pages 279-286

  Cunnion, Kenji M ^a,b   Buescher, E Stephen ^a   Hair, Pamela S ^a  

^a CHILDREN S HOSPITAL OF THE KING S DAUGHTERS   (United States)

^b CENTER FOR PEDIATRIC RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3B; COMPLEMENT FACTOR H; COMPLEMENT FACTOR I;

ARTICLE; BACTERIAL COUNT; BACTERIAL IMMUNITY; BACTERIAL SURVIVAL; CELL SURFACE; CONTROLLED STUDY; DISEASE COURSE; HOST RESISTANCE; HUMAN; HUMAN CELL; NEUTROPHIL; NONHUMAN; NORMAL HUMAN; PHAGOCYTOSIS; SERUM; STAPHYLOCOCCUS AUREUS;

ANTIBODIES, BLOCKING; COMPLEMENT C3B; COMPLEMENT FACTOR I; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; NEUTROPHILS; OPSONIN PROTEINS; PHAGOCYTOSIS; STAPHYLOCOCCUS AUREUS;

EID: 26844433272     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lab.2005.07.001     Document Type: Article

References (36)

1. Centers for Disease Control and Prevention Public health dispatch vancomycin resistant Staphylococcus aureus - Pennsylvania, 2002 Morb Mortal Wkly Rep 51 2002 902
2. Centers for Disease Control and Prevention National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 to June 2002, issued August 2002 Am J Infect Control 30 2002 458 475
3. D.J. Diekema, M.A. Pfaller, F.J. Schmitz, J. Smayevsky, J. Bell, R.N. Jones Survey of infections due to Staphylococcus species frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region of the SENTRY Antimicrobial Surveillance Program, 1997-1999 Clin Infect Dis 32 2001 114 132
4. J.M. Mylotte, C. McDermott, J.A. Spooner Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteremia Rev Infect Dis 9 1987 891 907
5. R.J. Rubin, C.A. Harrington, A. Poon, K. Dietrich, J.A. Greene, A. Moiduddin The economic impact of Staphylococcus aureus infection in New York City hospitals Emerg Infect Dis 5 1999 9 17
6. H.F. Chambers The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis 7 2001 178 181
7. A. Goetz, K. Posey, J. Flemming, S. Jacobs, L. Boody, M.M. Wagener Methicillin-resistant Staphylococcus aureus in the community a hospital-based study Infect Control Hosp Epidemiol 20 1999 689 691
8. F.D. Lowy Antimicrobial resistance the example of Staphylococcus aureus J Clin Invest 111 2003 1265 1273
9. M.M. Frank, J.P. Atkinson Complement system K.F. Austen M.M. Frank J.P. Atkinson H. Cantor Samter's immunologic diseases 2001 Lippincott Williams and Wilkins New York 281 298
10. K.M. Cunnion, D.K. Benjamin, C.G. Hester, M.M. Frank Role of complement receptors 1 and 2 (CD35 and CD21), C3, C4, and C5 in survival by mice of Staphylococcus aureus bacteremia J Lab Clin Med 143 2004 358 365
11. P.C. Leijh, M.T. van den Barselaar, M.R. Daha, R. van Furth Participation of immunoglobulins and complement components in the intracellular killing of Staphylococcus aureus and Escherichia coli by human granulocytes Infect Immun 33 1981 714 724
12. P.K. Peterson, B.J. Wilkinson, Y. Kim, D. Schmeling, P.G. Quie Influence of encapsulation on staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes Infect Immun 19 1978 943 949
13. H.A. Verbrugh, P.K. Peterson, B.-Y.T. Nguyen, S.P. Sisson, Y. Kim Opsonization of encapsulated Staphylococcus aureus the role of specific antibody and complement J Immunol 129 1982 1681 1687
14. J. Verhoef, P.K. Peterson, Y. Kim, L.D. Sabatu, P.G. Quie Opsonic requirements for staphylococcal phagocytosis heterogeneity among strains Immunol 33 1977 191 197
15. K.M. Cunnion, J.C. Lee, M.M. Frank Capsule production and growth phase influence binding of complement to Staphylococcus aureus Infect Immun 69 2001 796 803
16. K.M. Cunnion, P.S. Hair, E.S. Buescher Cleavage of complement C3b to iC3b on the surface of Staphylococcus aureus is mediated by serum complement factor I Infect Immun 72 2004 2858 2863
17. D.L. Gordon, J. Rice, J.J. Finlay-Jones, P.J. McDonald, M.K. Hostetter Analysis of C3 deposition and degradation on bacterial surfaces after opsonization J Infect Dis 157 1988 697 704
18. J.M. Ahern, A.M. Rosengard Complement receptors J.E. Volanakis M.M. Frank The human complement system in health and disease 1998 Marcel Dekker New York 167 202
19. E.J. Brown, K.A. Joiner, T.A. Gaither, C.H. Hammer, M.M. Frank The interaction of C3b bound to pneumococci with factor H (β1H globulin), factor I (C3b/C4b inactivator), and properdin factor B of the human complement system J Immunol 131 1983 409 415
20. L.F. Fries, G.M. Prince, T.A. Gaither, M.M. Frank Factor I co-factor activity of CR1 overcomes the protective effect of IgG on covalently bound C3b residues J Immunol 135 1985 2673 2679
21. T.A. Gaither, C.H. Hammer, M.M. Frank Studies of the molecular mechanisms of C3b inactivation and a simplified assay of β1H and the C3b inactivator (C3bINA) J Immunol 123 1979 1195 1204
22. J.D. Lambris, A. Sahu, R.A. Wetsel The chemistry and biology of C3, C4, and C5 J.E. Volanakis M.M. Frank The human complement system in health and disease 1998 Marcel Dekker New York 83 118
23. B.P. Morgan Physiology and pathophysiology of complement progress and trends Crit Rev Clin Lab Sci 32 1995 265 298
24. R.D. Arbeit, W.W. Karakawa, W.F. Vann, J.B. Robbins Predominance of two newly described capsular polysaccharide types among clinical isolates of Staphylococcus aureus Diagn Microbiol Infect Dis 2 1984 85 91
25. Na'was T, Hawwari A, Hendrix E, Hebden J, Edelman R, Martin M, et al. Phenotypic and genotypic characterization of nosocomial Staphylococcus aureus isolates from trauma patients. J Clin Microbiol 198;36:414-20.
26. D. Sompolinsky, Z. Samra, W.W. Karakawa, W.F. Vann, R. Schneerson, Z. Malik Encapsulation and capsular types in isolates of Staphylococcus aureus from different sources and relationship to phage types J Clin Microbiol 22 1985 828 834
27. P.S. Hair, K.H. Schoenbach, E.S. Buescher Sub-microsecond, intense pulsed electric field applications to cells show specificity of effects Bioelectrochemistry 61 2001 65 72
28. K. Berggren, E. Chernkalskaya, T.H. Steinberg, C. Kemper, M.F. Lopez, Z. Diwu Background-free, high sensitivity staining of proteins in one- and two-dimensional sodium dodecyl sulfate-polyacrylamide gels using a luminescent ruthenium complex Electrophoresis 21 2000 2509 2521
29. K.M. Cunnion, H.-M. Zhang, M.M. Frank Availability of complement bound to Staphylococcus aureus to interact with membrane complement receptors influences efficiency of phagocytosis Infect Immun 71 2003 656 662
30. M.K. Liszewski, J.P. Atkinson Regulatory proteins of complement J.E. Volanakis M.M. Frank The human complement system in health and disease 1998 Marcel Dekker New York 149 166
31. C. Neeleman, S.P.M. Geelen, P.C. Aerts, M.R. Daha, T.E. Mollnes, J.J. Roord Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H Infect Immun 67 1999 4517 4524
32. R. Janulczyk, F. Iannelli, G. Sjoholm, G. Pozzi, L. Bjorck Hic, a novel surface protein of Streptococcus pneumoniae that interferes with complement function J Biol Chem 275 2002 37257 37263
33. R.D. Horstmann, H.J. Sievertsen, J. Knobloch, V.A. Fischetti Antiphagocytic activity of streptococcal M protein selective binding of complement control protein factor H Proc Nat Acad Sci USA 85 1988 1657 1661
34. V. Pandiripally, E. Gregory, D. Cue Acquisition of regulators of complement activation by Streptococcus pyogenes serotype M1 Infect Immun 70 2002 6202 6214
35. A. Sahu, S.N. Isaacs, A.M. Soulika, J.D. Lambris Interaction of Vaccinia virus complement control protein with human complement proteins factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway J Immunol 160 1998 5596 5604
36. O.B. Spiller, D.J. Blackbourn, L. Mark, D.G. Proctor, A.M. Blom Functional activity of the complement regulator encoded by Kaposi's sarcoma-associated Herpesvirus J Biol Chem 278 2003 2983 2989